BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25189639)

  • 1. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.
    Del Pino M; Svanholm-Barrie C; Torné A; Marimon L; Gaber J; Sagasta A; Persing DH; Ordi J
    Mod Pathol; 2015 Feb; 28(2):312-20. PubMed ID: 25189639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOP2A/MCM2, p16
    Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
    BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
    Shroyer KR; Homer P; Heinz D; Singh M
    Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.
    Bala R; Pinsky BA; Beck AH; Kong CS; Welton ML; Longacre TA
    Am J Surg Pathol; 2013 May; 37(5):659-68. PubMed ID: 23552383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
    Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
    Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Liu W; Gong J; Xu H; Zhang D; Xia N; Li H; Song K; Lv T; Chen Y; Diao Y; Jao J; Dai S; Zhao P; Yao Q
    Diagn Cytopathol; 2020 Jul; 48(7):635-644. PubMed ID: 32275355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
    J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.
    Wei Q; Fu B; Liu J; Xu J; Zhao T
    Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening].
    Xu T; Lu HJ; He YF
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of cytodiagnostics, molecular identification of HPV HR and CINtecPLUS test to identify LG SIL and HG SIL.
    Rokita W; Kedzia W; Pruski D; Friebe Z; Nowak-Markwitz E; Spaczyński R; Karowicz-Bilińska A; Spaczyński M
    Ginekol Pol; 2012 Dec; 83(12):894-8. PubMed ID: 23488290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
    Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
    Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
    Bose S; Evans H; Lantzy L; Scharre K; Youssef E
    Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL; Dye T; Grace C; Hiraoka M
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.